Physician profile
Mohammad Arfeen
NPI 1932640075
$8,223.68
in general payments reported to CMS, 2019-2025
14 companies · $1,125 in 2025
The $1,125 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2022: $740 · 2023: $2,018 · 2024: $4,096 · 2025: $1,125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,735 · Food and Beverage: $2,504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,735.27 |
| Food and Beverage | $2,503.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,562.64 | 2023-2025 | Resolution 360 Clip, Overstitch Nxt Endoscopic Suturing System, Axios |
| Olympus Corporation of The Americas | $2,221.33 | 2022-2025 | Single Use Electrosurgical Knife Kd-655, Disposable Distal Attachment, Olympus |
| Ovesco Endoscopy USA, INC. | $686.17 | 2024 | |
| Olympus America INC. | $431.81 | 2024-2025 | Single Use Electrosurgical Knife Kd-655, Disposable Emr Kit, Single Use Repositionable Clip |
| Medtronic, INC. | $360.98 | 2022-2023 | Gi Genius |
| Abbvie INC. | $271.19 | 2019-2023 | Rinvoq |
| Janssen Biotech, INC. | $152.73 | 2022-2024 | Tremfya |
| Micro-Tech Endoscopy USA, INC. | $140.03 | 2024 | |
| Intercept Pharmaceuticals, INC. | $127.98 | 2023 | Ocaliva |
| Omega Medical Imaging, LLC | $79.66 | 2024-2025 | |
| Fujifilm Healthcare Americas Corporation | $75.00 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $71.62 | 2022-2023 | Entyvio |
| Genzyme Corporation | $29.06 | 2024 | |
| Travere Therapeutics, INC. | $13.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Arfeen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.